AIDS. Conditional approval touted.
Nowak
R
R
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D015704:CD4 Antigens / Q000032:analysis; D004359:Drug Therapy, Combination; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration; D016047:Zalcitabine / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use
D015704:CD4 Antigens; D015215:Zidovudine; D016047:Zalcitabine